<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58537</article-id><article-id pub-id-type="doi">10.7554/eLife.58537</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Homology-guided identification of a conserved motif linking the antiviral functions of IFITM3 to its oligomeric state</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-173834"><name><surname>Rahman</surname><given-names>Kazi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2986-0007</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188024"><name><surname>Coomer</surname><given-names>Charles A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188025"><name><surname>Majdoul</surname><given-names>Saliha</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0530-6354</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188026"><name><surname>Ding</surname><given-names>Selena Y</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4413-644X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-188027"><name><surname>Padilla-Parra</surname><given-names>Sergi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8010-9481</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-148633"><name><surname>Compton</surname><given-names>Alex A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7508-4953</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">HIV Dynamics and Replication Program, Center for Cancer Research</institution>, <institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Frederick</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">HIV Dynamics and Replication Program</institution>, <institution>National Cancer Institute</institution>, <addr-line><named-content content-type="city">Frederick</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Infectious Diseases</institution>, <institution>King's College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-6168"><name><surname>Marsh</surname><given-names>Mark</given-names></name><role>Reviewing editor</role><aff><institution>University Coillege London</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>alex.compton@nih.gov</email> (AC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>28</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58537</elocation-id><history><date date-type="received"><day>04</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>27</day><month>10</month><year>2020</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58537-v1.pdf"/><abstract><p>The interferon-inducible transmembrane (IFITM) proteins belong to the Dispanin/CD225 family and inhibit diverse virus infections. IFITM3 reduces membrane fusion between cells and virions through a poorly characterized mechanism. Mutation of proline rich transmembrane protein 2 (PRRT2), a regulator of neurotransmitter release, at glycine-305 was previously linked to paroxysmal neurological disorders in humans. Here, we show that glycine-305 and the homologous site in IFITM3, glycine-95, drive protein oligomerization from within a GxxxG motif. Mutation of glycine-95 (and to a lesser extent, glycine-91) disrupted IFITM3 oligomerization and reduced its antiviral activity against Influenza A virus. An oligomerization-defective variant was used to reveal that IFITM3 promotes membrane rigidity in a glycine-95-dependent and amphipathic helix-dependent manner. Furthermore, a compound which counteracts virus inhibition by IFITM3, amphotericin B, prevented the IFITM3-mediated rigidification of membranes. Overall, these data suggest that IFITM3 oligomers inhibit virus-cell fusion by promoting membrane rigidity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Intramural Research Program</award-id><principal-award-recipient><name><surname>Rahman</surname><given-names>Kazi</given-names></name><name><surname>Coomer</surname><given-names>Charles A</given-names></name><name><surname>Majdoul</surname><given-names>Saliha</given-names></name><name><surname>Ding</surname><given-names>Selena Y</given-names></name><name><surname>Compton</surname><given-names>Alex A</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC-2019-CoG-863869 FUSION</award-id><principal-award-recipient><name><surname>Padilla-Parra</surname><given-names>Sergi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-58537-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>